Leerink Partners & Stifel
8 shared events · Importance 3 · Last updated Jul 01, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Business
Leerink Partners: Leerink Partners is acting as a joint bookrunning manager for the public offering by Tango Therapeutics, assisting in the sale of securities.
Stifel: Stifel is acting as a joint bookrunning manager for the public offering by Tango Therapeutics, contributing to the management of the offering.
Jun 08, 2026 · 8 articles
Business
Leerink Partners: Leerink Partners is acting as a joint book-running manager for Trevi Therapeutics' public offering.
Stifel: Stifel is acting as a joint book-running manager for Trevi Therapeutics' public offering.
Apr 16, 2026 · 7 articles
Business
Leerink Partners: Leerink Partners is acting as a joint bookrunning manager for Neurogene's public offering.
Stifel: Stifel is acting as a joint bookrunning manager for Neurogene's public offering.
Jun 30, 2026 · 6 articles
Business
Leerink Partners: Leerink Partners acted as a joint book-running manager for the IPO, earning fees and enhancing its reputation in biotech capital markets.
Stifel: Stifel's global head of ECM commented on the biotech IPO market, reflecting its involvement in capital markets.
Jul 06, 2026 · 25 articles
Business
Leerink Partners: Served as lead financial advisor to XOMA Royalty.
Stifel: Acted as lead financial advisor to Ligand.
Jul 14, 2026 · 6 articles
Regulatory
Leerink Partners: Leerink analyst Andrew Berens commented that the launch delay was not anticipated.
Stifel: Stifel analyst Kohen Wiley commented on the delayed launch, noting it was somewhat extended.
Jul 17, 2026 · 7 articles
Business
Leerink Partners: Leerink Partners>>> served as an advisor to GSK plc>>> in the acquisition.
Stifel: Stifel provided a note in April regarding the potential total biopharma M&A value for 2026.
Jun 09, 2026 · 56 articles
Business
Leerink Partners: Investment bank; previously commented on Palsonify's approval.
Stifel: Analyst firm; analyst Paul Matteis commented on deal price.
Jul 06, 2026 · 34 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Leerink Partners and Stifel interact across events, view sentiment trends, and discover connected entities.
Open Dashboard